Top Story

FDA grants orphan drug designation to pancreatic cancer treatment

December 22, 2014

The FDA granted orphan drug designation to a pancreatic cancer treatment in development by Nuvilex Inc., the company announced today.

The targeted chemotherapy treatment combines Cell-in-a-Box — Nuvilex’s patented and proprietary cellulose-based encapsulation technology — with the cancer prodrug ifosfamide and encapsulated live cells that convert the prodrug into its cancer-killing form.

In the Journals

Nitrogenous bisphosphonate use may reduce risk for endometrial cancer

December 22, 2014
Exposure to nitrogenous bisphosphonates appeared to have a protective effect on the incidence of endometrial cancer in women who never had the malignancy, according to…
First-line fulvestrant extended OS in advanced, ER-positive breast cancer Meeting News Coverage

First-line fulvestrant extended OS in advanced, ER-positive breast cancer

December 22, 2014
SAN ANTONIO — First-line fulvestrant significantly extended OS compared with anastrozole in women with advanced, ER-positive breast cancer, according to results of…
Ixazomib may provide more convenient, effective treatment for multiple myeloma Meeting News CoverageVideo

Ixazomib may provide more convenient, effective treatment for multiple myeloma

December 21, 2014
SAN FRANCISCO — Shaji K. Kumar, MD, professor of medicine at the Mayo Clinic in Rochester, Minn., discusses the experimental agent, ixazomib, which may…
Vosaroxin combination demonstrated improved survival in AML Meeting News CoverageVideo

Vosaroxin combination demonstrated improved survival in AML

December 20, 2014
SAN FRANCISCO — Farhad Ravandi, MD, professor of medicine in the department of leukemia at The University of Texas MD Anderson Cancer Center, discusses data from…
More News Headlines »
CME CNE
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
Meeting News Coverage Video
Vosaroxin combination demonstrated improved survival in AML

Vosaroxin combination demonstrated improved survival in AML

December 20, 2014
SAN FRANCISCO — Farhad Ravandi, MD, professor of medicine in the department of leukemia at The University of…
More »
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
morganatic-roan
morganatic-roan